Effects of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and their combination on microalbuminuria in normotensive patients with type 2 diabetes-Reference-Cited by-同舟云学术

Effects of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and their combination on microalbuminuria in normotensive patients with type 2 diabetes

Published:2006-07 Issue:4 Volume:23 Page:615-622
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Therapy

Author:

Atmaca Aysegul,Gedik Olcay

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02850049.pdf

Reference23 articles.

1. Dinneen SF, Gerstein H. The association of microalbuminuria and mortality in non-insulindependent diabetes mellitus: a systematic overview of the literature.Arch Intern Med. 1997; 157:1413–1418.

2. McKenna K, Thompson C. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.Scott Med J. 1997;42:99–104.

3. Bjorck S, Mulec H, Johnsen SA, Norden G, Aurell M. Renal protective effect of enalapril in diabetic nephropathy.BMJ. 1992;304:339–343.

4. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for The Collaborative Study Group. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy.N Engl J Med. 1993;329: 1456–1462.

5. Parving HH, Rossing P, Hommel E, Smidt UM. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years’ experience.Am J Kidney Dis. 1995;26:99–107.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29

2. The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis;Nephrology Dialysis Transplantation;2023-06-12

3. Efficacy and safety of dual blockade of the renin-angiotensin-aldosterone system in diabetic kidney disease: A meta-analysis;Diabetic Nephropathy;2023-06-01

4. Renal Effects of High-Dose Versus Low-Dose Lisinopril in Patients With Diabetic Nephropathy;Cureus;2022-10-03

5. Efficacy and safety of dual vs single renin–angiotensin–aldosterone system blockade in chronic kidney disease;Medicine;2021-09-03